Release Date: 07/04/16 11:10 Summary: Scheme Meeting Results-CKL.AX Price Sensitive: No Download Document 191.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%